HCMV jogs the ‘memory’ of NK cells in HBV

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Immunotherapy of hepatocellular carcinoma
Hepatic CD141+IFNλ+ DC subset: One against all?
R. Cavallo  Clinical Microbiology and Infection 
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
Engineering Natural Killer Cells for Cancer Immunotherapy
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 52, Issue 3, Pages (March 2010)
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Determinants of hepatic effector CD8+ T cell dynamics
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Biology of the immunomodulatory molecule HLA-G in human liver diseases
بلوغ و تمایز لنفوسیت های B
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Engineering Natural Killer Cells for Cancer Immunotherapy
Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 68, Issue 3, Pages (March 2018)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
A dive into the complexity of type I interferon antiviral functions
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Liver is liver and blood is blood, and finally the twain have met
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 70, Issue 3, Pages (March 2019)
Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C
Economics of chronic hepatitis B and hepatitis C
Percy A. Knolle, Robert Thimme  Gastroenterology 
Volume 42, Issue 4, Pages (April 2005)
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 56, Issue 6, Pages (June 2012)
Immigration and viral hepatitis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Volume 62, Issue 3, Pages (March 2015)
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Reply to: “Flow cytometry makes all the difference”
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Presentation transcript:

HCMV jogs the ‘memory’ of NK cells in HBV Upkar S. Gill, Lucy Golden-Mason  Journal of Hepatology  Volume 70, Issue 3, Pages 343-345 (March 2019) DOI: 10.1016/j.jhep.2018.11.009 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Differences in FcεRIγ+ and FcεRIγ− CD56dim mature NK cells in HBV. FcεRIγ− CD56dim NK cells are depicted as memory-like NK cells with differential receptor expression, a diverse transcription profile along with epigenetic and metabolic alterations compared to conventional FcεRIγ+ CD56dim NK cells, following exposure to HCMV. In addition, memory-like NK cells undergo increased cytokine responses and CD16-mediated ADCC. ADCC, antibody-dependent cell cytotoxicity; HBV, hepatitis B virus; HCMV, human cytomegalovirus; IFN, interferon; NCR, natural cytotoxicity receptor; NK, natural killer. Journal of Hepatology 2019 70, 343-345DOI: (10.1016/j.jhep.2018.11.009) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions